Current perspectives on control of equine influenza

Veterinary Research

Volumn 35, Issue 4, 2004, Pages 411-423

  Daly, Janet M ^a   Newton, J Richard ^a   Mumford, Jennifer A ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Epidemiology; Equine influenza; Surveillance; Vaccine strain selection

Indexed keywords

FLUAVERT IN VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LIVE VACCINE; PROTEQ FLU; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY RESPONSE; ANTIGEN PRESENTATION; CELLULAR IMMUNITY; DIAGNOSTIC TEST; DIFFUSION; DRUG EFFICACY; DRUG POTENCY; HEMOLYSIS; HORSE DISEASE; INFECTION CONTROL; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MATHEMATICAL MODEL; NONHUMAN; RESPIRATORY TRACT INFECTION; REVIEW; STANDARDIZATION; STRAIN DIFFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRUS SHEDDING;

ANIMALS; HORSE DISEASES; HORSES; INFLUENZA A VIRUS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION;

EQUIDAE; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 4444231435     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: 10.1051/vetres:2004023     Document Type: Review

References (71)

1. Askonas B.A., McMichael A.J., Webster R.G., The antibody response to influenza virus, in: Beare A.S. (Ed.), Basic and Applied Influenza Research, CRC Press, Boca Raton, Florida, 1982, pp. 164-181.
2. Binns M.M., Daly J.M., Chimside E.D., Mumford J.A., Wood J.M., Richards C.M., Daniels R.S., Genetic and antigenic analysis of an equine influenza H3 isolate from the 1989 epidemic, Arch. Virol. 130 (1993) 33-43.
3. Birch-Machin I, Rowan A., Pick J., Mumford J., Binns M., Expression of the nonstructural protein NS1 of equine influenza A virus: detection of Anti-NS1 antibody in post infection equine sera, J. Virol. Methods 65 (1997) 255-263.
4. Bryans J., Control of equine influenza, in: Bryans J.T. (Ed.), Proc. 1st Int. Conference on Equine Infectious Diseases, Stresa, Italy, 1966,pp.157-165.
5. Bryans J.T., The antibody response of horses to two inactivated oil adjuvanted equine influenza virus vaccines, in: International symposium on influenza vaccines for men and horses, Paris, France, 1973, pp. 311-317.
6. Burrows R., Denyer M., Antigenic properties of some equine influenza viruses, Arch. Virol. 73(1982)15-24.
7. Burrows R., Denyer M., Goodridge D., Hamilton F., Field and laboratory studies of equine influenza viruses isolated in 1979, Vet. Rec. 109(1981)353-356.
8. Cameron T.P., Alford R.H., Kasel J.A., Harvey E.W., Byrne R.J., Knight V., Experimental equine influenza in Chincoteague ponies, Proc. Soc. Exp. Biol. Med. 124 (1967) 510-515.
9. Chambers T.M., Shortridge K.F., Li P.H., Powell D.G., Watkins K.L., Rapid diagnosis of equine influenza by the Directigen FLU-A enzyme immunoassay, Vet. Rec. 135 (1994) 275-279.
10. Chambers T.M., Holland R.E., Tudor L.R., Townsend H.G.G., Cook A., Bogdan J., Lunn D.P., Hussey S., Whitaker-Dowling P., Youngner J.S., Sebring R.W., Penner SJ., Stiegler G.I., A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge, Equine Vet. J. 33 (2001) 630-636.
11. Cook R.F., Sinclair R., Mumford J.A., Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/ equine influenza (H3N8) viruses, J. Virol. Methods 20 (1988) 1-12.
12. Couch R.B., Kasel J.A., Immunity to influenza in man, Annu. Rev. Microbiol. 37 (1983) 529-549.
13. Cullinane A., Weld J., Osborne M., Nelly M., McBride C., Walsh C., Field studies on equine influenza vaccination regimes in Thoroughbred foals and yearlings, Vet. J. 161 (2001) 174-185.
14. Daly J.M., Lai A.C.K., Binns M.M., Chambers T.M., Barrandeguy M., Mumford J.A., Antigenic and genetic evolution of equine H3N8 influenza A viruses, J. Gen. Virol. 77 (1996) 661-671.
15. Daly J.M., Yates P.J., Browse G., Swann Z., Newton J.R., Jessett D., Davis-Poynter N., Mumford J.A., Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross-protection afforded by equine influenza vaccines, Equine Vet. J. 35(2003)458-462.
16. EMEA/CVMP/l12/98, Notes for guidance: harmonisation of requirements for equine influenza vaccines-specific requirements for substitution or addition of a strain or strains, 1998.
17. European Pharmacopoeia, Monograph on equine influenza vaccines, 3rd ed., 1998.
18. Evans T.G., Kallas E.G., Campbell M., Andrews J.D., Schwartz D., Keefer M., Caudrelier P., Evaluation of canarypox-induced CD8(+) responses following immunization be measuring the effector population IFNgamma production, Immunol. Lett. 77 (2001) 7-15.
19. Glass K., Wood J.L.N., Mumford J.A., Jessett D., Grenfell B.T., Modelling equine influenza 1: a stochastic model of within-yard epidemics, Epidemiol. Infect. 128 (2002) 491-502.
20. Gorse G.J., Patel G.B., Belshe R.B., HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers, AIDS Res. Hum. Retroviruses 17 (2001) 1175-1189.
21. Guo Y., Wang M., Zheng S., Wang P., Ji W., Chen Q., Aetiologic study on an influenza-like epidemic in horses in China, Acta Virol. 35(1991)190-195.
22. Guo Y., Wang M., Kawaoka Y., Gorman O., Ito T., Saito T., Webster R.G., Characterization of a new avian-like influenza A virus from horses in China, Virology 188 (1992) 245-255.
23. Guo Y., Wang M., Zhang G-S., Li W.-K., Kawaoka Y., Webster R.G., Seroepidemio-logical and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-1994, J. Gen. Virol. 76 (1995) 2009-2014.
24. Haaheim L.R., Schild G.C., Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 2. Antiviral activities of the antibodies in biological systems, Acta Pathol. Microbiol. Scand. B 88 (1980) 335-340.
25. Hannant D., Mumford J.A., Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells, Vet. Immunol. Immunopathol. 21 (1989) 327-337.
26. Hannant D., Mumford J.A., Jessett D.M., Duration of circulating antibody and immunity following infection with equine influenza virus, Vet. Rec. 122 (1988) 125-128.
27. Heinen P.P., de Boer-Luijtze E.A., Bianchi A.T.J., Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection, J. Gen. Virol. 82 (2001) 2697-2707.
28. Hinshaw V.S., Naeve,C.W., Webster R.G., Douglas A., Skehel J.J., Bryans J., Analysis of antigenic variation in equine 2 influenza A viruses, Bull. World Health Organ. 61 (1983) 153-158.
29. Kawaoka Y., Bean W.J., Webster R.G., Evolution of the hemagglutinin of equine H3 influenza viruses, Virology 169 (1989) 283-292.
30. Klingeborn B., Rockborn G., Dinter Z., Significant antigenic drift within the influenza equi 2 subtype in Sweden, Vet. Rec. 106 (1980)363-364.
31. Kumanomido T., Akiyama Y., Immunoeffect of serum and nasal antibody against experimental inoculation with influenza A-Equi-2 virus, Exp. Rep. Equine Health Lab. 12 (1975)44-52.
32. Liu I.K.M., Pascoe D.R., Chang L.W.S., Zee Y.C., Duration of maternally derived antibodies against equine influenza in newborn foals, Am. J. Vet. Res. 46 (1985) 2078-2080.
33. Livesay G.J., O'Neill T., Hannant D., Yadav M.P., Mumford J.A., The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA, Vet. Rec. 133 (1993) 515-519
34. Lunn D., Hussey S., Sebring R., Rushlow K., Radecki S., Whitaker-Dowling P., Youngner J., Chambers T., Holland R., Horohov D., Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immuno-suppression, J. Am. Vet. Med. Assoc. 218 (2001)900-906.
35. Martens J.G., Development and evaluation of aerosol delivery of antivirals for the treatment of equine virus induced respiratory infections, Diss. Abstr. Int. 47 (1986) 69.
36. McMichael A.J., Gotch F.M., Cullen P., Askonas B.A., Webster R.G., Cytotoxic T cell immunity to influenza, N. Engl. J. Med. 309 (1983) 13-17.
37. Morley P.S., Townsend H.G.G., Bogdan J.R., Haines D.M., Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses, J. Am. Vet. Med. Assoc. 215 (1999) 61-64.
38. Mumford J., Collaborative study for the establishment of three European Pharmacopoeia Biological Reference Preparations for equine influenza horse antiserum, Pharmeuropa (2000) 7-21.
39. Mumford J., Progress in the control of equine influenza, in: Plowright W., Rossdale P.D., Wade J.F. (Eds.), Proc. 6th Int. Conference on Equine infectious diseases, Cambridge, 1992, pp.207-218.
40. Mumford J.A., Wood J., Conference report on WHO/OIE meeting: Consultation on newly emerging strains of equine influenza, Vaccine 11 (1993) 1172-1175.
41. Mumford J.A., Wood J.M., Folkers C., Schild G.C., Protection against experimental infection with influenza virus A/equine/Miami/ 63(H3N8) provided by inactivated whole virus vaccines containing homologous virus, Epidermiol. Infect. 100 (1988) 501-510.
42. Mumford J.A., Jessett D.M., Rollinson E.A., Hannant D., Draper M.E., Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines, Vet. Rec. 134 (1994) 158-162.
43. Mumford J.A., Wilson H., Hannant D., Jessett D.M., Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant, Epidemiol. Infect. 112 (1994) 421-437.
44. Nelson K.M., Schram B.R., McGrergor M.W., Sheoran A.S., Olsen CW., Lunn D.P., Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination, Vaccine 16 (1998) 1306-1313.
45. Newton J.R., Verheyen K., Wood J.L.N., Yates P.J., Mumford J.A., Equine influenza in the United Kingdom in 1998, Vet. Rec. 145 (1999) 449-452.
46. Newton JR., Lakhani K.H., Wood J.L.N., Baker D.J., Risk factors for equine influenza serum antibody titres in young Thoroughbred racehorses given an inactivated vaccine, Prev. Vet. Med. 46 (2000) 129-141.
47. + cytotoxic T lymphocyte responses induced in mucosa-associated tissues, Virology 254 (1999) 50-60.
48. OIE, Conclusions and recommendations from the consultation meeting of OIE and WHO experts on equine influenza, Newmarket, United Kingdom, September 18-19, 1995, OIE Bull. 108 (1996) 482-484.
49. OIE Code, International Animal Health Code, 7th ed., Office International des Épizooties, Paris, France, 1998.
50. Ozaki H., Sugiura T., Sugita S., Imagawa H., Kida H., Detection of antibodies to the non-structural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses, Vet. Microbiol. 82 (2001) 111-119.
51. Park A.W., Wood J.L.N., Newton J.R., Daly J., Mumford J.A., Grenfell B.T., Optimising vaccination strategies in equine influenza, Vaccine 21 (2003) 2862-2870.
52. Plateau E., Crucière C., Virat J., Benazet P., Grippe équine : isolement, caractérisation et étude sérologique dans divers foyers au cours de l'épizootie 1978-1979, Bull. Acad. Vet. Fr. 52 (1979) 189-194.
53. Powell D.G., Burrows R., Spooner P., Mumford J., Thomson G., Field observations on influenza vaccination among horses in Britain, 1971-1976, Dev. Biol. Stand. 39 (1977) 347-352.
54. Powell D.G., Watkins K.L., Li P.H., Shortridge K.F., Outbreak of equine influenza among horses in Hong Kong during 1992, Vet. Rec. 136 (1995) 531-536.
55. Rouse B.T., Ditchfield J.B., The response of ponies to Myxovirus influenzae A-Equi-2 III. The protective effect of serum and nasal anti-body against experimental challenge, Res. Vet. Sci. 11 (1970) 503-507.
56. Rouse B.T., Ditchfield W.J.B., The response of ponies to Myxovirus influenzae A-equi 2 I. Serum and nasal antibody titres following exposure, Can. J. Comp. Med. 34 (1970) 1-6.
57. Scholtens R.G., Steele J.H., U.S. epizootic of equine influenza, 1963: epizootiology, Public Health Rep. Washington 79 (1964) 393-398.
58. Sovinová O., Tumová B., Pouska F., Nemec J., Isolation of a virus causing respiratory disease in horses, Acta Virol. 2 (1958) 51-61.
59. Thomson G.R., Spooner P.R., Powell D.G., The outbreak of equine influenza in England: January 1976, Vet. Rec. 100 (1977) 465-468.
60. Townsend H.G.G., Penner S.J., Watts T.C., Cook A., Bogdan J., Haines D.M., Griffin S., Chambers T., Holland R.E., Whitaker-Dowling P., Youngner J.S., Sebring R.W., Efficacy of a cold-adapted, intranasal equine influenza vaccine: challenge trials, Equine Vet. J. 33 (2001) 637-643.
61. Van Maanen C., Bruin G., de Boer-Luijtze E., Smolders G., de Boer G.F., Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza, Vet. Q. 14 (1992) 13-17.
62. Van Oirschot J.T., Masurel N., Huffels A.D.N.H., Anker W.J.J., Equine influenza in the Netherlands during the winter of 1978-1979; antigenic drift of the A-equi 2 virus, Vet. Q. 3 (1981) 81-84.
63. Van Oirschot J.T., Bruin G., de Boer-Luytze E., Smolders G., Maternal antibodies against equine influenza virus in foals and their interference with vaccination, Zentralbl. Veterinarmed. B 38 (1991) 391-396.
64. Waddell G.H., Teigland M.B., Sigel M.M., A new influenza virus associated with equine respiratory disease, J. Am. Vet. Med. Assoc. 143 (1963) 587-590.
65. Webster R.G., Yuanji G., New influenza virus in horses, Nature 351 (1991) 527.
66. Wernery R., Yates P.J., Wernery U., Mumford J.A., An equine influenza outbreak in a polo club in Dubai, United Arab Emirates in 1995/96, in: Wernery U., Wade J.F., Mumford J.A., Kaaden O.-R. (Eds.), Proc. 8th Int. Conference on Equine Infections Diseases, Dubai, 1998, pp. 342-346.
67. Wood J.M., Mumford J., Folkers C., Scott A.M., Schild G.C., Studies with inactivated equine influenza vaccine: I. Serological responses of ponies to graded doses of vaccine, J. Hyg. (Lond.) 90 (1983) 371-384.
68. Wood J.M., Schild G.C., Folkers C., Mumford J., Newman R.W., The standardization of inactivated equine influenza vaccines by single-radial immunodiffusion, J. Biol. Stand. 11 (1983) 133-136.
69. Yates P., Mumford J.A., Equine influenza vaccine efficacy: the significance of antigenic variation, Vet. Microbiol. 74 (2000) 173-177.
70. Yewdell J.W., Hackett C.J., The specificity and function of T lymphocytes induced by influenza A viruses, in: Krug R. (Ed.), The influenza viruses, Plenum Press, New York/ London, 1989, pp. 361-429.
71. Youngner J.S., Whitaker-Dowling P., Chambers T.M., Rushlow K.E., Sebring R., Derivation and characterization of a live attenuated equine influenza vaccine virus, Am. J. Vet. Res. 62 (2001) 1290-1294.